MUFG Americas’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-5
Closed -$2K 752
2020
Q4
$2K Buy
+5
New +$2.24K ﹤0.01% 702
2019
Q2
Sell
-35
Closed -$8K 835
2019
Q1
$8K Buy
+35
New +$7.22K ﹤0.01% 814
2015
Q2
Sell
-120
Closed -$9K 1210
2015
Q1
$9K Buy
120
+12
+11% +$934 ﹤0.01% 938
2014
Q4
$8K Hold
108
﹤0.01% 998
2014
Q3
$6K Sell
108
-26
-19% -$1.64K ﹤0.01% 1050
2014
Q2
$9K Hold
134
﹤0.01% 945
2014
Q1
$8K Buy
+134
New +$7.98K ﹤0.01% 926
2013
Q3
Sell
-42
Closed -$2K 1302
2013
Q2
$2K Buy
+42
New +$1.83K ﹤0.01% 1531

Other funds holding IDXX

MUFG Americas's IDXX Position: Q1 2021 in Review

MUFG Americas sold out of Idexx Laboratories (IDXX) in Q1 2021, closing a stake of 5 shares — an estimated $2K sold.

MUFG Americas first reported a position in IDXX in Q2 2013 and held it in 8 quarters. The position peaked at $9K in Q1 2015. 1,012 funds tracked by Wall St. Rank hold IDXX as of Q1 2021.

  • MUFG Americas reported no remaining Idexx Laboratories position as of Q1 2021 after selling out during the quarter.
  • MUFG Americas sold 5 Idexx Laboratories shares in Q1 2021, an estimated $2K.
  • MUFG Americas first reported a position in Idexx Laboratories in Q2 2013 and held it in 8 quarters.
  • MUFG Americas's Idexx Laboratories position peaked at $9K in Q1 2015.
  • 1,012 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2021.

Based on MUFG Americas's 13F filing for Q1 2021, filed 30 Apr 2021.